Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Postpartum Depression
Sort By
Newest First
1 / 1
1 / 1
FDA Approval
FDA Approves First Treatment for Postpartum Depression
U.S. Food & Drug Administration
PR-M03-19-NI-064
Mar 22, 2019
FDA Acceptance
Sage Therapeutics Announces FDA Acceptance of NDA Filing and Grant of Priority Review for Brexanolone IV in the Treatment of Postpartum Depression
Sage Therapeutics
PR-M06-18-NI-007
Jun 04, 2018
